LDR Holding Corporation
) have been rising and hit a 52-week high following the
announcement that the Current Procedural Terminology (CPT)
Editorial Panel has accepted the addition of Category I code
22858X as an add-on code to support two-level cervical
arthroplasty procedures. LDR Holding reached a new 52-week high
of $40.39 on Mar 13, 2014.
The rise in share price indicates positive market sentiment.
The codes will become effective Jan 1, 2015 onwards.
Simultaneously, the Category III code 0092T will be
With the new code effective from Jan 2015, patient access to
LDR Holding's Mobi-C cervical disc replacement device will
improve as a full coding and payment structure will be in
Mobi-C cervical disc replacement device was approved by the
U.S. Food and Drug Administration (FDA) for two-level indications
in Aug 2013. Mobi-C is unique as it is the only cervical disc
replacement device to be approved by the FDA for both one and
The CPT coding is a major milestone in the history of cervical
disc replacement. According to information provided by the
company, the emerging U.S. cervical disc replacement market is
slated to grow 26% annually from $148 million in 2013 to $601
million by 2018. LDR Holding estimates that about 30% of patients
undergoing anterior cervical surgery require two-level
Considering LDR Holding's Mobi-C cervical disc replacement
device is approved for one and two-level use, there is
significant potential for the company to penetrate and drive
growth of the cervical disc replacement market.
LDR Holding currently bears a Zacks Rank #3 (Hold). Some
better-ranked stocks worth considering in the overall medical
Syneron Medical Ltd.
Natus Medical Inc.
). All these stocks carry a Zacks Rank #1 (Strong Buy).
NATUS MEDICAL (BABY): Free Stock Analysis
CYNOSURE INC-A (CYNO): Free Stock Analysis
SYNERON MED LTD (ELOS): Free Stock Analysis
LDR HOLDING (LDRH): Free Stock Analysis
To read this article on Zacks.com click here.